ArticleFrontiers in immunology2021

"γδT Cell-IL17A-Neutrophil" Axis Drives Immunosuppression and Confers Breast Cancer Resistance to High-Dose Anti-VEGFR2 Therapy.

Zhigang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.